作为癌症免疫景观调节者的长非编码RNA:在免疫瘤学中聚焦HEIH
Adham H Mohamed1, Mohamed A Ragheb1, Habiba M Ismail2
1Department of Chemistry (Biochemistry Division), Faculty of Science, Cairo University, Giza 12613, Egypt.
Critical reviews in oncology/hematology
|August 12, 2025
概括
长非编码RNAs (lncRNAs) 调节癌症的进展和免疫反应. 肝细胞癌上调的EZH2相关 lncRNA (HEIH) 具有双重瘤和免疫调节功能,标记其为潜在的癌症治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 癌症和免疫系统之间的相互作用显著影响瘤进展和治疗结果.
- 长非编码RNAs (lncRNAs) 是参与生理和病理过程的基因表达的关键调节者.
- lncRNAs在人类恶性瘤中发挥关键作用,影响瘤生长,转移和免疫调节.
研究的目的:
- 阐明 lncRNAs 在癌症进展中的作用,重点关注它们的免疫调节功能.
- 专门研究肝细胞癌在各种癌症中的双重瘤和免疫调节作用上调EZH2-关联lncRNA (HEIH).
主要方法:
- 审查有关lncRNAs,癌症生物学和免疫学的现有文献.
- 对研究HEIH在不同癌症类型中的表达和功能的研究进行分析.
- 关于HEIH在瘤生长,存活和免疫规避中的分子机制的数据综合.
主要成果:
- lncRNAs参与调节瘤微环境和对免疫治疗的反应.
- HEIH被确定为一种在多种癌症中表达高的瘤基因,促进了扩散和存活.
- 新出现的证据表明,HEIH具有重要的,但尚未研究的免疫调节功能.
结论:
- 包括HEIH在内的lncRNAs在癌症发育和免疫逃避中至关重要.
- HEIH既具有致癌性,也具有免疫调节性,这凸显了它在恶性瘤中的复杂作用.
- HEIH代表了新瘤治疗的有前途的治疗标.
相关概念视频
lncRNA - Long Non-coding RNAs
8.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K
Immune Surveillance by NK Cells and Phagocytes
2.8K
Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
2.8K
Cytotoxic T Cells-mediated Immune Response
2.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.0K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Non-LTR Retrotransposons
11.9K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.9K
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660


